What is idarucizumab used for?
Idarucizumab is an FDA-approved medicine used to rapidly reverse the anticoagulant effect of dabigatran in people who need emergency surgery or urgent procedures, or who have uncontrolled or life-threatening bleeding. It works by binding to dabigatran so the drug can’t keep anticoagulation active [1][2].
How does idarucizumab work?
Idarucizumab is a monoclonal antibody fragment (a targeted binding agent). It binds dabigatran with high affinity, neutralizing dabigatran’s anticoagulant activity quickly [1][2].
How fast does idarucizumab act?
Clinical labeling describes rapid reversal, with effects on coagulation parameters occurring within minutes after administration. The intent is to restore normal blood clotting quickly for urgent clinical situations [1][2].
How is idarucizumab given, and what is the dose?
Idarucizumab is given by intravenous infusion as a dosing regimen specified in its prescribing information. The standard approach is two consecutive doses, administered one after the other, totaling the labeled amount [1][2].
Who can get idarucizumab?
It is indicated for patients taking dabigatran who require reversal due to:
- life-threatening or uncontrolled bleeding, or
- the need for emergency surgery or urgent procedures [1][2].
Does idarucizumab replace anticoagulation after reversal?
Idarucizumab reverses dabigatran’s anticoagulant effect, but it does not prevent clotting by itself. After reversal, clinicians decide whether and when to restart anticoagulation based on the patient’s bleeding and clotting risk (as described in clinical guidance/labeling context) [1][2].
What side effects do patients ask about?
Commonly reported adverse reactions include issues such as headache and nausea, and infusion-related reactions can occur. The prescribing information lists specific adverse events and frequencies [1][2].
Is idarucizumab the only dabigatran reversal option?
Idarucizumab is the specific reversal agent for dabigatran. Other anticoagulant reversal agents exist for other drugs/classes, but idarucizumab is tailored to dabigatran [1][2].
If someone already took dabigatran, will idarucizumab still work?
Yes. The purpose of idarucizumab is to reverse dabigatran’s anticoagulant effect even when dabigatran has already been taken, including in urgent/emergency settings [1][2].
Sources
- Idarucizumab (Pradaxa reversal) – FDA label / prescribing information (official prescribing info)
- Idarucizumab – EMA product information / EPAR materials